Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Change in Acquisitions & Divestments (2023 - 2025)

Metagenomi (MGX) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $52.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 26.15% to $52.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $170.5 million, a 22.99% decrease, with the full-year FY2025 number at $170.5 million, down 22.99% from a year prior.
  • Change in Acquisitions & Divestments was $52.0 million for Q4 2025 at Metagenomi, up from $33.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $101.5 million in Q4 2023 to a low of $33.5 million in Q3 2025.
  • A 3-year average of $54.6 million and a median of $48.6 million in 2023 define the central range for Change in Acquisitions & Divestments.
  • Biggest YoY gain for Change in Acquisitions & Divestments was 81.62% in 2024; the steepest drop was 59.38% in 2024.
  • Metagenomi's Change in Acquisitions & Divestments stood at $101.5 million in 2023, then plummeted by 59.38% to $41.2 million in 2024, then rose by 26.15% to $52.0 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Change in Acquisitions & Divestments are $52.0 million (Q4 2025), $33.5 million (Q3 2025), and $37.7 million (Q2 2025).